Monogenic systemic lupus erythematosus: insights in pathophysiology

Rheumatol Int. 2018 Oct;38(10):1763-1775. doi: 10.1007/s00296-018-4048-7. Epub 2018 May 15.

Abstract

Systemic lupus erythematosus (SLE) is a complex disease with different genetic, immunologic, and environmental factors contributing to the pathogenesis. Monogenic SLE could help us understand the main phases of immune dysregulation in SLE. The aim of this review is to summarize the current knowledge on monogenic SLE with the implications of the respective genes on disease pathogenesis. A comprehensive literature search on monogenic SLE was conducted utilizing the Cochrane Library and MEDLINE/PubMed databases. The main affected pathways in disease pathogenesis are identified as follows: complement system, apoptosis, nucleic acid degradation, nucleic acid sensing, self-tolerance, and type I interferon production. Further studies on monogenic SLE can make precision medicine possible for SLE by increasing our understanding of disease pathogenesis.

Keywords: Apoptosis; Complement system; Monogenic SLE; Self-tolerance; Systemic lupus erythematosus.

Publication types

  • Review

MeSH terms

  • Animals
  • Apoptosis* / drug effects
  • Apoptosis* / genetics
  • Complement Activation* / drug effects
  • Complement Activation* / genetics
  • Complement System Proteins / genetics
  • Complement System Proteins / immunology*
  • Genetic Predisposition to Disease
  • Humans
  • Immunologic Factors / therapeutic use
  • Interferon Type I / genetics
  • Interferon Type I / immunology*
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / genetics
  • Lupus Erythematosus, Systemic / immunology
  • Lupus Erythematosus, Systemic / physiopathology*
  • Nucleic Acids / genetics*
  • Nucleic Acids / metabolism
  • Phenotype
  • Self Tolerance* / drug effects
  • Self Tolerance* / genetics

Substances

  • Immunologic Factors
  • Interferon Type I
  • Nucleic Acids
  • Complement System Proteins